Due to health issues, this site is no longer maintained and will be shut down shortly.

PHGE BiomX Inc.

Develops drugs for cancer treatment

$0.32  +0.01 (3.77%)
As of 03/27/2023 10:19:34 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/28/2019
Outstanding shares:  33,181,773
Average volume:  242,809
Market cap:   $10,691,167
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy